ArticleCancer biology & therapy2011

Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.

Tunde O Akinyeke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.